Outcomes of cochlear implantation in patients with neurofibromatosis type 2

References

• Aristegui, M., Denia, A. 2005. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma). Otol Neurotol, 26: 205–10. doi: 10.1097/00129492-200503000-00013
   PubMed Web of Science ®Google Scholar
• Carlson, M.L., Breen, J.T., Driscoll, C.L., Link, M.J., Neff, B.A., Gifford, R.H., et al. 2012. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol, 33: 853–62. doi: 10.1097/MAO.0b013e318254fba5
   PubMed Web of Science ®Google Scholar
• Celis-Aguilar, E., Lassaletta, L., Gavilan, J. 2012. Cochlear implantation in patients with neurofibromatosis type 2 and patients with vestibular schwannoma in the only hearing ear. Int J Otolaryngol, 2012: Article ID 157497. doi:10.1155/2012/157497
   PubMedGoogle Scholar
• Graham, J., Lynch, C., Weber, B., Stollwerck, L., Wei, J., Brookes, G. 1999. The magnetless Clarion cochlear implant in a patient with neurofibromatosis 2. J Laryngol Otol, 113: 458–63.
   PubMed Web of Science ®Google Scholar
• Hoffman, R.A., Kohan, D., Cohen, N.L. 1992. Cochlear implants in the management of bilateral acoustic neuromas. Am J Otol, 13: 525–8.
   PubMedGoogle Scholar
• Lassaletta, L., Aristegui, M., Medlina, M., Aranguez, G., Perez-Mora, R., Falcioni, M., et al. 2016. Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2. Eur Arch Otorhinolaryngol, 273: 27–35. doi: 10.1007/s00405-014-3450-3
   PubMed Web of Science ®Google Scholar
• Lloyd, S.K., Evans, D.G. 2013. Neurofibromatosis type 2 (NF2): diagnosis and management. Handb Clin Neurol, 115: 957–67. doi: 10.1016/B978-0-444-52902-2.00054-0
   PubMedGoogle Scholar
• Lloyd, S.K., Glynn, F., Rutherford, S., King, A.T., Mawman, D., O'Driscoll, M., et al. 2014. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with Neurofibromatosis type 2. Otol Neurotol, 35(1): 43–51. doi: 10.1097/MAO.0000000000000185
   PubMed Web of Science ®Google Scholar
• Mallory, G.W., Pollock, B.E., Foote, R.L., Carlson, ML, Driscoll, C.L., Link, M.J. 2014. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes. Neurosurgery, 74(3): 292–300. doi: 10.1227/NEU.0000000000000264
   PubMed Web of Science ®Google Scholar
• Matthies, C., Brill, S., Kaga, K., Morita, A., Kumakawa, K., Skarzynski, H., et al. 2013. Auditory brainstem implantation improves speech recognition in Neurofibromatosis type 2 patients. ORL, 75: 282–95. doi: 10.1159/000350568
   Google Scholar
• Moffat, D.A., Lloyd, S.K., Macfarlane, R., Mannion, R., King, A.T., Rutherford, S.A., et al. 2013. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2. Br J Neurosurg, 27(4): 446–53. doi: 10.3109/02688697.2013.771143
   PubMed Web of Science ®Google Scholar
• Mukherjee, P., Ramsden, J.D., Donnelly, N., Axon, P., Saeed, S., Fagan, P., et al. 2013. Cochlear implants to treat deafness caused by vestibular schwannomas. Otol Neurotol, 34(7): 1291–8. doi: 10.1097/MAO.0b013e31829763a7
   PubMed Web of Science ®Google Scholar
• Neff, B.A., Wiet, R.M., Lasak, J.M., Cohen, N.L., Pillsbury, H.C., Ramsden, R.T., et al. 2007. Cochlear implantation in the neurofibromatosis type 2 patient: long tern follow-up. Laryngoscope, 117: 1069–72. doi: 10.1097/MLG.0b013e31804b1ae7
   PubMed Web of Science ®Google Scholar
• Nolle, C., Todt, I., Basta, D., Unterberg, A., Mautner, V.F., Ernst, A. 2003. Cochlear implantation after acoustic tumour resection in neurofibromatosis type 2: impact of intra and post-operative neural response telemetry monitoring. ORL J Otorhinolaryngol Relat Special, 65: 230–4. doi: 10.1159/000073122
   PubMed Web of Science ®Google Scholar
• Plotkin, S.R., Merker, V.L., Halpin, C., Jennings, D., McKenna, M.J., Harris, G.J., et al. 2012. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol, 33(6): 1046–52. doi: 10.1097/MAO.0b013e31825e73f5
   PubMed Web of Science ®Google Scholar
• Roehm, P.C., Mallen-St Clair, J., Jethanamest, D., Golfinos, J.G., Shapiro, W., Waltzman, S., et al. 2011. Auditory rehabilitation of patients with neurofibromatosis type 2 by using cochlear implants. J Neurosurg, 115: 827–34. doi: 10.3171/2011.5.JNS101929
   PubMed Web of Science ®Google Scholar
• Tono, T., Ushisako, Y., Morimitsu, T. 1996. Cochlear implantation in an intralabyrinthine acoustic neuroma patient after resection of an intracanalicular tumour. J Laryngol Otol, 110: 570–3. doi: 10.1017/S0022215100134292
   PubMed Web of Science ®Google Scholar
• Trotter, M.I., Briggs, R.J. 2010. Cochlear implantation in neurofibromatosis type 2 after radiation therapy. Otol Neurotol, 31(2): 216–9. doi: 10.1097/MAO.0b013e3181c348e7
   PubMed Web of Science ®Google Scholar
• Tran Ba Huy, P., Kania, R., Frachet, B., Poncet, C., Legac, M.-S. 2009. Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2. Acta Oto-laryngol, 129: 971–5. doi: 10.1080/00016480802510202
   PubMed Web of Science ®Google Scholar
• Tysome, J.R., Axon, P.R., Donnelly, N.P., Evans, D.G., Ferner, R.E., O'Connor, A.F., et al. 2013. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2. Otol Neurotol, 34(9): 1743–7. doi: 10.1097/MAO.0b013e3182a1a8b4
   PubMed Web of Science ®Google Scholar
• Vincenti, V., Pasanisi, E., Guida, M., Di Trapani, G., Sanna, M. 2008. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus brainstem implantation. Audiol Neurotol, 13: 273–80. doi: 10.1159/000115437
   PubMed Web of Science ®Google Scholar
• Wackym, P.A., Michel, M.A., Prost, R.W., Banks, K.L., Runge-Samuelson, C.L., Firszt, J.B.. 2004. Effect of magnetic resonance imaging on internal magnet strength in Med-El Combi 40+ cochlear implants. Laryngoscope, 114(8): 1355–61. doi: 10.1097/00005537-200408000-00007
   PubMed Web of Science ®Google Scholar
• Walton, J., Donnelly, N.P., Tam, Y.C., Joubert, I., Durie-Gair, J, Jackson, C, et al. 2014. MRI without magnet removal in neurofibromatosis type 2 patients with cochlear and auditory brainstem implants. Otol Neurotol, 35(5): 821–5. doi: 10.1097/MAO.0000000000000330
   PubMed Web of Science ®Google Scholar